-+ 0.00%
-+ 0.00%
-+ 0.00%

PROPANC BIOPHARMA - PLANS PHASE 1B STUDY IN 40–45 PATIENTS WITH ADVANCED SOLID TUMORS, CLINICAL TRIAL APPLICATION EXPECTED IN COMING MONTHS

Reuters·08/27/2026 12:30:01

Please log in to view news